ArticlePediatric cardiology2026
Leaflet Length is a Reliable Measure of Aortic Valve Growth.
Article in Pediatric cardiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The advent of partial heart transplant (PHT) of living valves necessitates robust measures of valve growth. Traditional measurement of aortic valve annular dimension can be confounded by cardiac dilation and does not evaluate the growth of aortic valve leaflets. Measurement of valve leaflet length growth over time has not been studied. We conducted a retrospective cohort study of 12 infants post–orthotopic heart transplant (OHT) and 12 infants with ventricular septal defects (VSDs) with ≥ 5 years of serial echocardiographic data. Leaflet length and annular dimension were measured, and inter-rater reliability assessed. Aortic leaflet length demonstrated good inter-rater reliability and consistent growth over time. Leaflet length is a reliable, feasible, and theoretically dilation-independent measure of semilunar valve growth and may improve longitudinal assessment in patients undergoing PHT.
Indexed as
Identifiers
41995821What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.